Showing results (31-40 of 4,635) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|July 16, 2010
Targeted therapy in advanced colorectal cancer: more data, more questionsSebastian L Ochenduszko, Krzysztof Krzemieniecki
Anti-Cancer Drugs|July 15, 2010
Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cellsShan Zhang, Xiao-Ling Wang, Ye-Hua Gan, et al.
Anti-Cancer Drugs|July 15, 2010
Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in miceGian Wan Soo, Jason H K Law, Elaine Kan, et al.
Anti-Cancer Drugs|December 22, 2010
Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answersKrisztian Homicsko, Dominik R Berthold
Anti-Cancer Drugs|December 22, 2010
Non-clear cell advanced kidney cancer: is there a gold standard?Pedro Sánchez, Emiliano Calvo, Ignacio Durán
Anti-Cancer Drugs|October 16, 2010
Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activationTing Zhang, Yun-Mian He, Jin-Song Wang, et al.
Anti-Cancer Drugs|October 1, 2010
Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylationWei Zhao, Tao Zhang, Bingqian Qu, et al.
Anti-Cancer Drugs|September 10, 2010
A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancerAhmed Dahmani, Ludmilla de Plater, Charlotte Guyader, et al.
Anti-Cancer Drugs|February 9, 2011
Temsirolimus in advanced leiomyosarcomas: patterns of response and correlation with the activation of the mammalian target of rapamycin pathwayAntoine Italiano, Michèle Kind, Eberhard Stoeckle, et al.
Anti-Cancer Drugs|February 3, 2009
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic featuresAlessandra Balduzzi, Emilia Montagna, Vincenzo Bagnardi, et al.
Pageof 464